Published in Mol Immunol on January 23, 2009
Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther (2011) 1.31
Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol (2010) 1.16
C3a and C5a promote renal ischemia-reperfusion injury. J Am Soc Nephrol (2012) 1.05
Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus. Cell Mol Immunol (2012) 0.95
Treatment targets in systemic lupus erythematosus: biology and clinical perspective. Arthritis Res Ther (2012) 0.90
Genetic Deficiency of Complement Component 3 Does Not Alter Disease Progression in a Mouse Model of Huntington's Disease. J Huntingtons Dis (2012) 0.78
Targeting the complement cascade: novel treatments coming down the pike. Kidney Int (2016) 0.75
Complement in Lupus Nephritis: New Perspectives. Kidney Dis (Basel) (2015) 0.75
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol (2007) 12.72
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99
Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol (2005) 4.26
The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev (2003) 3.96
The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (1996) 3.73
Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med (2004) 2.68
The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol (2004) 2.67
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest (1998) 2.60
Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A (2006) 2.41
A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature (2000) 2.24
Modulation of dendritic cell trafficking to and from the airways. J Immunol (2006) 2.17
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest (2006) 2.15
Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J Immunol (2005) 1.94
C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol (2002) 1.88
Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. J Biol Chem (2006) 1.79
Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest (1996) 1.74
Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J Exp Med (2007) 1.74
IL-10 regulates murine lupus. J Immunol (2002) 1.70
CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J Clin Invest (2001) 1.69
Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int (1985) 1.67
Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol (2000) 1.59
Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol (2000) 1.57
Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol (2000) 1.55
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol (2001) 1.47
Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol (2003) 1.45
Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J (2003) 1.42
Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol (2002) 1.40
Lungkine, a novel CXC chemokine, specifically expressed by lung bronchoepithelial cells. J Immunol (1999) 1.29
Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol (2005) 1.28
C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J Am Soc Nephrol (2005) 1.26
Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int (2008) 1.25
Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J Immunol (2001) 1.24
Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur J Immunol (2007) 1.23
Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2. J Immunol (1996) 1.23
Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol (1995) 1.23
The germinal center response is impaired in the absence of T cell-expressed CXCR5. Eur J Immunol (2007) 1.20
A homolog of the human chemokine receptor CXCR1 is expressed in the mouse. Mol Immunol (2005) 1.18
C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol (2005) 1.16
Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol (2002) 1.15
Genetics of SLE in mice. Springer Semin Immunopathol (2006) 1.11
Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. Br J Pharmacol (2004) 1.11
Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis. Kidney Int (2007) 1.10
Genetics of systemic autoimmunity in mouse models of lupus. Int Rev Immunol (2000) 1.09
Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J Immunol (2005) 1.08
Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol (2007) 1.08
IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol (1999) 1.07
Activated human T lymphocytes express a functional C3a receptor. J Immunol (2000) 1.04
Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg). J Immunol (1999) 1.03
The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J Clin Invest (2004) 1.03
The C3a receptor antagonist SB 290157 has agonist activity. Immunol Lett (2005) 1.01
Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. J Immunol (2006) 1.01
Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a. Mol Immunol (2007) 1.01
Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response. J Immunol (1997) 1.00
Susceptibility genes in the pathogenesis of murine lupus. Arthritis Res (2002) 1.00
Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J Am Soc Nephrol (2003) 0.99
Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis. J Immunol (2005) 0.99
C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line, HMC-1. J Immunol (2004) 0.97
C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression. J Virol (2006) 0.96
Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J Immunol (2004) 0.95
Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies. Immunology (1999) 0.95
C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Clin Exp Immunol (2002) 0.94
Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes. Brain Res Mol Brain Res (2003) 0.94
Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Lab Invest (2008) 0.91
C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor. Kidney Int (1999) 0.89
Chemoattractant receptors expressed on type 2 T cells and their role in disease. Int Arch Allergy Immunol (2001) 0.88
Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a. J Immunol (1999) 0.88
Review of autoimmune (lupus-like) glomerulonephritis in murine models. Ultrastruct Pathol (2006) 0.87
Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin. Immunology (2001) 0.87
Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci. Rev Immunogenet (2000) 0.85
Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions. J Immunol (2006) 0.81
Ablation of the complement C3a anaphylatoxin receptor causes enhanced killing of Pseudomonas aeruginosa in a mouse model of pneumonia. Am J Physiol Lung Cell Mol Physiol (2006) 0.80
The functional role of complement genes in systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol (1989) 0.79
Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med (2006) 5.26
Embryo-specific silencing of a transporter reduces phytic acid content of maize and soybean seeds. Nat Biotechnol (2007) 2.86
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood (2007) 2.72
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest (2003) 2.39
Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem (2002) 2.00
A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 1.74
Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J (2006) 1.70
Inhibition of complement activation by a secreted Staphylococcus aureus protein. J Infect Dis (2004) 1.62
Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci (2008) 1.58
Mycobacteria-primed macrophages and dendritic cells induce an up-regulation of complement C5a anaphylatoxin receptor (CD88) in CD3+ murine T cells. J Leukoc Biol (2006) 1.53
C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol (2004) 1.48
Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J (2003) 1.42
Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol (2002) 1.40
Association of genetic polymorphisms in the fibrinogen and platelet glycoprotein genes with unstable angina in Chinese patients. Clin Cardiol (2004) 1.39
A new mechanism regulating the initiation of allergic airway inflammation. J Allergy Clin Immunol (2007) 1.37
Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther (2010) 1.36
Carboxypeptidase N: a pleiotropic regulator of inflammation. Mol Immunol (2004) 1.32
C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J Am Soc Nephrol (2005) 1.26
The maize low-phytic acid mutant lpa2 is caused by mutation in an inositol phosphate kinase gene. Plant Physiol (2003) 1.24
Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. FASEB J (2012) 1.21
The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect Immun (2004) 1.21
Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J Immunol (2004) 1.21
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization. Proc Natl Acad Sci U S A (2013) 1.21
Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol (2003) 1.16
The regulation of liver cell survival by complement. J Immunol (2009) 1.15
Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model. J Neurosci (2009) 1.14
The maize low-phytic acid 3 encodes a myo-inositol kinase that plays a role in phytic acid biosynthesis in developing seeds. Plant J (2005) 1.12
A protective role for the fifth complement component (c5) in allergic airway disease. Am J Respir Crit Care Med (2006) 1.09
Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils. J Immunol (2004) 1.07
The relationship between pulse wave velocity and pulse pressure in Chinese patients with essential hypertension. Hypertens Res (2003) 1.06
Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice. J Leukoc Biol (2007) 1.06
Increasing the imaging depth of spectral-domain OCT by using interpixel shift technique. Opt Express (2006) 1.05
Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun (2003) 1.02
Facile synthesis of mesoporous spinel NiCo₂O₄ nanostructures as highly efficient electrocatalysts for urea electro-oxidation. Nanoscale (2014) 1.01
Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a. Mol Immunol (2007) 1.01
A high-throughput assay for quantification of starch hydrolase inhibition based on turbidity measurement. J Agric Food Chem (2011) 1.00
Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock. J Immunol (2009) 0.98
Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J Immunol (2004) 0.95
Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Am J Kidney Dis (2011) 0.94
The dopamine transporter gene, a spectrum of most common risky behaviors, and the legal status of the behaviors. PLoS One (2010) 0.91
Prevalence of enteroviruses in children with and without hand, foot, and mouth disease in China. BMC Infect Dis (2013) 0.91
miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. Cancer Lett (2013) 0.90
Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest (2006) 0.90
Urine proteome analysis in murine nephrotoxic serum nephritis. Am J Nephrol (2009) 0.90
Anti-mouse mesangial cell serum induces acute glomerulonephropathy in mice. Nephron Exp Nephrol (2003) 0.89
Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. Arthritis Res Ther (2007) 0.88
Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist. Kidney Int (2008) 0.87
A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis. Tuberculosis (Edinb) (2011) 0.87
Cardio-ankle vascular index relates to left ventricular ejection fraction in patients with heart failure. A retrospective study. Int Heart J (2013) 0.86
Highly enantioselective [4 + 2] cycloadditions of allenoates and dual activated olefins catalyzed by N-acyl aminophosphines. Org Biomol Chem (2012) 0.86
Immunoglobulin locus associates with serum IgG levels and albuminuria. J Am Soc Nephrol (2011) 0.85
Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am J Hypertens (2008) 0.84
The complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in dextran sulfate sodium (DSS)-induced colitis in mice. PLoS One (2013) 0.84
Cytomegalovirus and recurrent idiopathic membranoproliferative glomerulonephritis type 1: cause or consequence? Transplantation (2007) 0.83
Aerobic denitrification by Pseudomonas stutzeri C3 incapable of heterotrophic nitrification. Bioprocess Biosyst Eng (2014) 0.83
Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury. FASEB J (2013) 0.83
Thiourea-phosphonium salts from amino acids: cooperative phase-transfer catalysts in the enantioselective aza-Henry reaction. Chem Commun (Camb) (2013) 0.83
Pediatric hypertension: diagnosis, evaluation, management, and treatment for the primary care physician. Curr Probl Pediatr Adolesc Health Care (2005) 0.82
Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft models. Mol Cancer (2012) 0.82
Complement C3a regulates Muc5ac expression by airway Clara cells independently of Th2 responses. Am J Respir Crit Care Med (2007) 0.82
Proteomic profiling of urinary protein excretion in the factor H-deficient mouse. Am J Nephrol (2006) 0.82
Expression of microRNA-122 contributes to apoptosis in H9C2 myocytes. J Cell Mol Med (2012) 0.82
Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura. Clin J Am Soc Nephrol (2011) 0.82
Antioxidant activity and proanthocyanidin profile of Selliguea feei rhizomes. Molecules (2013) 0.81
A site-specific genetic modification for induction of pluripotency and subsequent isolation of derived lung alveolar epithelial type II cells. Stem Cells (2014) 0.81
Cobalt chloride induces neurite outgrowth in rat pheochromocytoma PC-12 cells through regulation of endothelin-2/vasoactive intestinal contractor. J Neurosci Res (2005) 0.81
RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury. Exp Neurol (2011) 0.81
Expression of the third complement component (C3) and carboxypeptidase N small subunit (CPN1) during mouse embryonic development. Dev Comp Immunol (2004) 0.81
Hepatocyte nuclear factor 1 and hypertensive nephropathy. Hypertension (2008) 0.81
Sodium titanate nanotubes as negative electrode materials for sodium-ion capacitors. ACS Appl Mater Interfaces (2012) 0.81
Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice. PLoS One (2012) 0.80
Specific IgG4 production during house dust mite immunotherapy among age, gender and allergic disease populations. Int Arch Allergy Immunol (2012) 0.80
Ablation of the complement C3a anaphylatoxin receptor causes enhanced killing of Pseudomonas aeruginosa in a mouse model of pneumonia. Am J Physiol Lung Cell Mol Physiol (2006) 0.80
Tolerance of an aerobic denitrifier (Pseudomonas stutzeri) to high O2 concentrations. Biotechnol Lett (2013) 0.80
C1q nephropathy in the pediatric population: pathology and pathogenesis. Pediatr Nephrol (2010) 0.79
The complement C3a receptor is critical in defense against Chlamydia psittaci in mouse lung infection and required for antibody and optimal T cell response. J Infect Dis (2013) 0.79
CdSe-ZnS quantum dots for selective and sensitive detection and quantification of hypochlorite. Anal Chem (2010) 0.79
Total synthesis of (±)-sculponeatin N. Org Lett (2013) 0.79
Role of total hip replacement arthroplasty between transplantation and acute kidney injury. Ren Fail (2014) 0.77
Isolation and characterization of alveolar epithelial type II cells derived from mouse embryonic stem cells. Tissue Eng Part C Methods (2013) 0.77
Therapeutic targets for metastatic prostate cancer. Curr Drug Targets (2003) 0.77
Peer Influence, Genetic Propensity, and Binge Drinking: A Natural Experiment and a Replication. AJS (2015) 0.77
Fast and highly efficient removal of dyes under alkaline conditions using magnetic chitosan-Fe(III) hydrogel. Water Res (2011) 0.77
Cryptococcosis associated with crescentic glomerulonephritis. Pediatr Nephrol (2008) 0.77
Complement factor C7 contributes to lung immunopathology caused by Mycobacterium tuberculosis. Clin Dev Immunol (2012) 0.77
Domestic wastewater treatment in a novel sequencing batch biofilm filter. Appl Microbiol Biotechnol (2015) 0.76
Denaturation and unfolding of human anaphylatoxin C3a: an unusually low covalent stability of its native disulfide bonds. Arch Biochem Biophys (2008) 0.76
Spherical carbon-coated natural graphite as a lithium-ion battery-anode material. Angew Chem Int Ed Engl (2003) 0.76
Correction: Bacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore Persistence. PLoS Pathog (2016) 0.75
[A retrospective study of the efficacy and toxicity of irinotecan in combination with nedaplatin versus irinotecan in combination with cisplatin as salvage treatment in refractory or relapsed small cell lung cancer]. Zhongguo Fei Ai Za Zhi (2013) 0.75
Microbial community changes during the start-up of an anaerobic/aerobic/anoxic-type sequencing batch reactor. Environ Technol (2013) 0.75
[Efficacy of chemotherapy after EGFR-TKIs resistance in 191 patients with Unknow EGFR gene mutation in advanced lung adenocarcinoma]. Zhongguo Fei Ai Za Zhi (2013) 0.75
Development and validation of a rapid and sensitive UPLC-MS/MS method for determination of total docetaxel from a lipid microsphere formulation in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.75
Increasing the catalytic activities of iodine doped titanium dioxide by modifying with tin dioxide for the photodegradation of 2-chlorophenol under visible light irradiation. J Hazard Mater (2011) 0.75
Graft polymerization of styrene initiated by covalently bonded peroxide groups on silica. J Colloid Interface Sci (2007) 0.75